期刊文献+

脂多糖预处理对VEGF165、Ang-1与HMGBx1在缺血-再灌注损伤心肌中表达的影响

Effects of LPS preconditioning on expressions of VEGF165,Ang-1 and HMGBx1 in myocardium underwent ischemia-reperfusion injury
原文传递
导出
摘要 目的探讨脂多糖预处理对血管内皮生长因子(VEGF165)、促血管生成素1(Ang-1)与高迁移率族蛋白B1(HMGBx1)在缺血-再灌注损伤心肌中表达的影响。方法普通B6小鼠制作心肌缺血-再灌注动物模型,实验组手术前给予脂多糖。用TUNEL检测心肌细胞凋亡状况,用凝胶迁移率实验(EMSA)检测核转录因子(NF-κB)的活力,用Western blot检测VEGF165、Ang-1、HMGBx1在心肌中的表达。大鼠心肌成肌细胞H9c2,转染携带人VEGF165和Ang-1的腺病毒,随后过氧化氢刺激,检测HMGBx1的胞浆含量和NF-κB的活性。结果小剂量脂多糖预处理能显著促进VEGF165、Ang-1在缺血-再灌注损伤心肌中的早期表达,并同时显著减少HMGBx1的表达和抑制心肌细胞凋亡。细胞实验提示VEGF165和Ang-1联合使用能显著减少心肌细胞胞浆中HMGBx1的含量和NF-κB的活性。结论 VEGF165和Ang-1可能通过抑制NF-κB的活性,减少HMGBx1的含量而对心肌细胞产生直接保护作用。 Objective To investigate the effects of LPS preconditioning on the expressions of vascular endothelial growth factor 165(VEGF165),angiopoietin-1(Ang-1) and high mobility group box1(HMGBx1) in the myocardium underwent ischemia-reperfusion(I-R) injury induced.MethodsIn vivo experiment,mice were pretreated with LPS before ligation of the left anterior descending coronary,which was followed by I-R.HMGBx1,VEGF165 and Ang-1 were assessed by immunoblotting.In situ cardiac,myocyte was examined by TUNEL assay.Ad-VEGF165 or/and Ad-Ang-1 or Ad-GFP was added into the medium of H9c2,and the cells were stimulated with hydrogen peroxide(H2O2) after transfection.Neuclear factor(NF-κB) activity was analyzed by electrophoretic mobility shift assay(EMSA) and HMGBx1 was assessed by immunoblotting.ResultsLPS pretreatment significantly promoted early expressions of VEGF165 and Ang-1 in the myocardium after I-R injury,reduced the expression of HMGBx1 and apoptosis of myocytes.HMGBx1 and NF-κB activities were significantly decreased by combined use of VEGF165 and Ang-1.Conclusion VEGF 165 and Ang-1 have a direct myocardial protective effects,possibly through inhibiting NF-κB activity and reducing HMGBx1.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第16期1920-1923,F0003,共5页 Jiangsu Medical Journal
基金 国家自然科学基金面上项目(30872544)
关键词 心肌缺血-再灌注 血管内皮生长因子165 促血管生成素1 高迁移率族蛋白 Myocardial ischemia-reperfusion Vascular endothelial growth factor 165 Angiopoietin-1 High mobility group box1
  • 相关文献

参考文献13

  • 1刘翔,陈亦江,张馥敏,陈丽珍,哈团柱,高翔,李传富.VEGF_(165)和Ang-1协同改善急性心梗大鼠心功能[J].中华胸心血管外科杂志,2005,21(5):295-297. 被引量:11
  • 2Liu X, Chen Y, Zhang F, et al. Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium[J]. Scand Cardiovasc J, 2007,41 (2) : 95-101.
  • 3Ha T, Hua F, Liu X, et al. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism [J]. Cardiovasc Res, 2008,78 (3) : 546-553.
  • 4Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB-1 mediates hepatic injury after murine liver ischemia- reperfusion[J]. J Exp Med, 2005,201(7) : 1135-1143.
  • 5Qiu J,Nishimura M,Wang Y,et al. Early release of HMGB-1 from neurons after the onset of brain ischemia[J]. J Cereb Blood Flow Metab, 2008,28 (5) : 927-938.
  • 6Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia- reperfusion[J]. J Exp Med, 2005,201 (7) : 1135-1143.
  • 7Wu H,Chen G,Wyburn KR,et al. TLR4 activation mediates kidney ischemia/reperfusion injury[J]. J Clin Invest, 2007, 117 (10) : 2847-2859.
  • 8Andrassy M, Volz HC, Igwe JC, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart[J]. Circulation, 2008,117(25) : 3216-3226.
  • 9Zhou L, Ma W,Yang Z,et al. VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways[J]. Gene Ther, 2005,12 (3) : 196-202.
  • 10刘旭冬,于灵芝,韩友群,姜丽.大鼠脑缺血再灌注损伤时脑组织血管内皮生长因子和内皮抑素的变化[J].中华麻醉学杂志,2009(6):550-552. 被引量:1

二级参考文献29

  • 1马璟曦,罗勇.电针对大鼠局灶脑缺血再灌注后脑内血管生长因子和血管抑制因子表达的影响[J].中国针灸,2007,27(2):129-133. 被引量:44
  • 2刘旭冬,于灵芝,徐长宪,郭兰敏,边雯.大鼠脊髓缺血再灌注损伤后血清内皮抑素和VEGF的相关性研究[J].中国神经精神疾病杂志,2007,33(2):110-112. 被引量:4
  • 3Hierlihy AM, Seale P, Lobe CG, et al. The post-natal heart contains a myocardial stem cell population. FEBS Letters, 2002,530:239-243.
  • 4Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells angiogenesis. Science,1997,275:964-967.
  • 5Ziegler BL, Valtier M, Porada GA, et al. KDR receptor: a key marker defining hematopoietic stem cells. Science,1999,285:1553-1558.
  • 6Yuasa H, Takakura N, Shimomua T, et al. Analysis of human TIE2 funtion on hematopoietic stem cells in umbilical cord blood. Biochem Biophys Res Commun,2002,298:731-737.
  • 7Moore MA, Hattori K, Heissig B, et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1,VEGF, and angiopoietin-1. Ann N Y Acad Sci,2001,938:36-45;
  • 8Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infracted myocardium. Nature,2001,410:701-705.
  • 9Rabbany SY, Heissing B, Hattori K, et al. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revasculariation. Trends Mol Med, 2003,9:109-117.
  • 10Szmitko PE, Fedak PWM, Weisel RD, et al. Endothelial progenitor cells new hope for broken heart.Circulation,2003,107:3093-3100.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部